
Please try another search
Chengdu Olymvax Biopharmaceuticals Inc. engages in the research and development, production, and sales of vaccines for human use. It offers adsorbed tetanus vaccine; Hib conjugate vaccine; Group A streptococcus vaccine; and AC conjugate vaccine. The company also provides vaccines for haemophilus influenzae type b; group A and C meningococcal; and staphylococcus aureus, which is in Phase 3 clinical trial. In addition, it engages in technology promotion and application services business; biotechnology, R&D, and consulting. The company was founded in 2009 and is based in Chengdu, China.
Name | Age | Since | Title |
---|---|---|---|
Shaowen Fan | 69 | - | Genenral Manager & Chairman of the Board |
Fan Fan | 41 | - | Director & Deputy General Manager |
Cheng Xie | 29 | 2019 | Supervisor |
Cheng Hu | - | - | Vice Chairman of the Board and Deputy General Manager |
Aimin Chen | - | - | Director and Deputy General Manager |
Shaowen Fan | 69 | 2010 | Chairman of the Board & GM |
Lu Lu | 68 | 2022 | Employee Representative Director |
Aimin Chen | 69 | - | Director |
Pengfei Zhang | 39 | 2016 | Chairman of Supervisory Board |
Shao Ping He | 67 | 2019 | Independent Director |
Yunhui Yu | 61 | 2013 | Director |
Yunhui Yu | 61 | 2013 | Director |
Hua Yan | 58 | 2022 | Supervisor |
Cheng Hu | 57 | 2022 | Director |
Fan Fan | 44 | 2010 | Vice Chairman of the Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review